Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Amphastar Pharmaceuticals Company Profile (NASDAQ:AMPH)

Consensus Ratings for Amphastar Pharmaceuticals (NASDAQ:AMPH) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $16.50 (37.04% upside)

Analysts' Ratings History for Amphastar Pharmaceuticals (NASDAQ:AMPH)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/13/2014Jefferies GroupBoost Price TargetBuy$14.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
8/6/2014BMO Capital MarketsBoost Price Target$17.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
7/21/2014Needham & Company LLCInitiated CoverageBuy$17.00ViewTweet This Rating  Share This Rating on StockTwits
7/21/2014Piper JaffrayInitiated CoverageOverweight$16.00ViewTweet This Rating  Share This Rating on StockTwits
7/21/2014BMO Capital MarketsInitiated CoverageOutperform$17.00ViewTweet This Rating  Share This Rating on StockTwits
7/21/2014Jefferies GroupInitiated CoverageBuy$14.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/20/2012 forward)